For Research Use Only · Not For Human or Veterinary Use · Not FDA-Approved
Home · Catalog · Repair and recovery research compounds · KLOW (BPC-157, GHK-Cu, TB-500, KPV) 80 mg
A sealed Merit Klow (BPC157 + GHK-Cu 50 + TB500 + KPV) vial, 80 mg of lyophilized research compound
Independently assayed · HPLC ≥99%

KLOW (BPC-157, GHK-Cu, TB-500, KPV) 80 mg

Lyophilized vial

$174.99

Per vial

Select your pack size

Single

Ships within 48 hours from San Antonio

UPS Ground · tracked + insured · released after independent lab testing

  • Purity Guarantee. If a batch fails our ≥99% HPLC standard, full refund + replacement.
  • Batch certificate in the COA library, anytime, free
  • Same reorder price — forever, no upcharge

$174.99

Single

Independently assayedLicensed US facilitySan Antonio, TX

KLOW (BPC-157, GHK-Cu, TB-500, KPV) in brief

KLOW (BPC-157, GHK-Cu, TB-500, KPV) is a co-formulation of BPC-157, GHK-Cu, TB-500 and KPV in one vial; each component is studied separately in repair and inflammation research. None of its components (BPC-157, GHK-Cu, TB-500, KPV) is approved by the FDA for any use, and no FDA-approved product combines them. Supplied for research use only.

Independently Assayed≥99% PurityIndependently Assayed · Licensed US Facility48hr Dispatch from San Antonio

— About this compound

KLOW (BPC-157, GHK-Cu, TB-500, KPV).

Class · Merit co-formulation: BPC-157 + GHK-Cu + TB-500 + KPV

Origin. KLOW is a Merit-specific four-component co-formulation. It extends the GLOW blend with KPV, the C-terminal tripeptide (lysine-proline-valine) of alpha-melanocyte-stimulating hormone (α-MSH).

KLOW combines four peptides recurrent in repair and immune-signaling research: BPC-157, GHK-Cu, TB-500, and KPV. KPV is the C-terminal fragment of α-MSH and is studied for anti-inflammatory signaling that appears, in some models, to act independently of the melanocortin-1 receptor.

As a co-formulation, KLOW has no separate published record; the literature belongs to each component. Merit supplies it as a single research preparation for laboratory use only.

— Common research applications

  • Tissue-repair and remodeling research (component-based)
  • Inflammation-pathway models (KPV)
  • Extracellular-matrix studies
  • Comparative peptide co-formulation research

— Mechanism

How it's been studied.

Component-level: BPC-157 (cytoprotection / angiogenesis), GHK-Cu (matrix remodeling), TB-500 (actin / cell migration), and KPV (NF-κB-pathway modulation in inflammation models). No combined mechanism is established for the blend.

Mechanism descriptions reflect findings reported in the preclinical and basic-research literature. They are not clinical conclusions and not statements of therapeutic effect.

— The Chemistry

The numbers, plainly.

CAS

—

Molecular weight

—

Formula

—

Sequence

—

Format

Lyophilized powder

Vial dose

80 mg

Purity (HPLC)

≥99%

Amino acids

—

Half-life

Component-dependent (see the individual component records).

Solubility

Water-soluble. Physicochemical context only. Merit Sciences publishes no reconstitution or preparation procedures.

View the July 2026 batch certificate for KLOW (BPC-157, GHK-Cu, TB-500, KPV) 80 mg → or browse every certificate.

— Why Merit

The supplier difference.

How Merit compares to the two alternatives most research buyers consider for KLOW (BPC-157, GHK-Cu, TB-500, KPV).

Criterion
MeritLicensed US facility
Online ResellersRUO only
Compounding RxRx required
HPLC chromatogram per batch
sometimes
on request
Independent assay before release
QR code on the vial label opens the COA library
rarely
Ships from a licensed US facility
varies
Same reorder price — no markup over time
varies
48-hour dispatch

Comparison reflects published facility status and standard industry practice. Compounding pharmacy availability of research peptides varies by jurisdiction.

— How it's made

From compound to your shelf.

Every Merit batch follows the same documented path. Five steps, every one verifiable.

  1. 01

    Sourcing

    Compound starts as a research-grade API.

    Active pharmaceutical ingredient sourced from FDA-registered manufacturers. Identity confirmed against reference standard before any compounding begins.

    • API from FDA-registered manufacturers
    • Identity verified against reference standard
    • Chain of custody documented
  2. 02

    Compounding

    Sterile-filled in a US cleanroom.

    Lyophilized in a cleanroom at our US facility. The powder format gives ≥24 months sealed stability — no cold-chain shipping required.

    • Licensed US facility
    • Batch-documented manufacturing process
    • Lyophilized powder for transit stability
  3. 03

    Verification

    Every batch HPLC-tested.

    Reverse-phase HPLC-UV (UV/MS for higher-MW peptides) confirms identity and purity for every batch before it leaves the lab. The chromatogram is archived.

    • Reverse-phase HPLC, per-batch
    • ≥99% purity floor — every batch
    • Chromatogram archived for every batch
  4. 04

    Release

    The batch is released against an independent assay.

    No batch ships until an independent laboratory has returned its identity and purity results and the certificate is published in the COA library.

    • Independent laboratory on every batch
    • Certificate published before sale
    • Every certificate is in the public COA library
  5. 05

    Dispatch

    Ships from San Antonio in 48 hours.

    Sealed vials with a QR code on the label that opens the COA library. Order before 2pm CT Monday–Thursday for same-day dispatch. UPS Ground, tracked + insured.

    • 48hr dispatch from San Antonio, TX
    • QR code on every vial label
    • UPS Ground, tracked + insured

Every step above can be verified for any specific batch by emailing support@meritsciences.com with your order number.

— Research references

The published record.

Peer-reviewed work cited in the public scientific literature. Links resolve to PubMed or the publisher of record.

  1. 01

    PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation

    Dalmasso G, Charrier-Hisamuddin L, Nguyen HTT, et al. · Gastroenterology · 2008

  2. 02

    Stable Gastric Pentadecapeptide BPC 157: Novel Therapy in Gastrointestinal Tract

    Sikiric P, Seiwerth S, Rucman R, et al. · Current Pharmaceutical Design · 2011

Inclusion of a reference does not constitute a clinical claim or recommendation.

— Go deeper

Mechanism, published research and peer-reviewed references for KLOW Blend (BPC-157 · GHK-Cu · TB-500 · KPV), with no product attached.

— Common Questions

Got questions.

Is KLOW (BPC-157, GHK-Cu, TB-500, KPV) FDA-approved?+

None of its components (BPC-157, GHK-Cu, TB-500, KPV) is approved by the FDA for any use, and no FDA-approved product combines them. Supplied for research use only. Two components are named on the WADA 2026 Prohibited List: BPC-157 under S0 and TB-500 under S2.

How is each batch of KLOW (BPC-157, GHK-Cu, TB-500, KPV) tested?+

Every batch is tested by an independent laboratory for identity and HPLC purity before it is listed. Merit identifies batches by date: the current certificate for KLOW (BPC-157, GHK-Cu, TB-500, KPV) 80 mg is the July 2026 batch, 99.79% purity by HPLC, published at meritsciences.com/coa/COA-2026-5HUDMG. The QR code on each vial opens the same page. Open the July 2026 batch certificate →

What does the published research on KLOW (BPC-157, GHK-Cu, TB-500, KPV) show?+

KLOW has no published literature of its own; the research belongs to each component. The BPC-157, GHK-Cu, TB-500 and KPV monographs set out what each record shows and in which models. The KLOW Blend (BPC-157 · GHK-Cu · TB-500 · KPV) monograph at meritsciences.com/library/klow-blend lists the references. Read the KLOW Blend (BPC-157 · GHK-Cu · TB-500 · KPV) monograph →

What is KLOW (BPC-157, GHK-Cu, TB-500, KPV)?+

KLOW combines four peptides recurrent in repair and immune-signaling research: BPC-157, GHK-Cu, TB-500, and KPV. KPV is the C-terminal fragment of α-MSH and is studied for anti-inflammatory signaling that appears, in some models, to act independently of the melanocortin-1 receptor.

How does KLOW (BPC-157, GHK-Cu, TB-500, KPV) work?+

Component-level: BPC-157 (cytoprotection / angiogenesis), GHK-Cu (matrix remodeling), TB-500 (actin / cell migration), and KPV (NF-κB-pathway modulation in inflammation models). No combined mechanism is established for the blend.

What class of compound is KLOW (BPC-157, GHK-Cu, TB-500, KPV)?+

KLOW (BPC-157, GHK-Cu, TB-500, KPV) is classified as merit co-formulation: BPC-157 + GHK-Cu + TB-500 + KPV.

What is the reported half-life of KLOW (BPC-157, GHK-Cu, TB-500, KPV)?+

Component-dependent (see the individual component records).

Why does Merit ship lyophilized?+

Lyophilized (freeze-dried) material is stable in sealed storage: ≥24 months at -20°C. Peptides held in solution degrade far faster, so every compound ships as a dry powder in a sealed vial.

What does "independently assayed" actually mean?+

Every batch is tested by a laboratory independent of the facility that made it, and the certificate is published before the batch is listed. You read the same identity and purity figures we do, which is what separates Merit from a reseller catalog.

How fast does it ship?+

48 hours from order to dispatch, Monday through Thursday. UPS Ground, tracked + insured. From San Antonio, TX, most US addresses receive within 3-5 business days.

— Talk to a Pharmacologist

Question we didn't answer?

Our team answers compound and batch questions the same business day. No bots, no tickets.

Email the team →